- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 2.51M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $6.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.21M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.98M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.36M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.52M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.62M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.77M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $11.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.41M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 172.3K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $174K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.73M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.93M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $8.77M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$21.66 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$10.26 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.12M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.02M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$886K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.2M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $464K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $223K |
| Revenue | Q1 2025 · Mar 31, 2024 | $687K |